Windlas Biotech Limited (NSE:WINDLAS)
India · Delayed Price · Currency is INR 993.60
+5.40 (0.55%)
Aug 21, 2026, 3:29 PM IST
Windlas Biotech Market Cap
Windlas Biotech has a market cap or net worth of 20.5 billion as of August 21, 2026. Its market cap has decreased by -4.39% in one year.
Market Cap
20.50B
Enterprise Value
18.07B
Revenue
9.42B
Ranking
n/a
PE Ratio
31.92
Stock Price
993.60
ChartMarket Cap Chart
Since August 16, 2021, Windlas Biotech's market cap has increased from 8.87B to 20.50B, an increase of 131.07%. That is a compound annual growth rate of 18.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 20.50B | 23.05% |
| Dec 31, 2025 | 16.66B | -23.42% |
| Dec 31, 2024 | 21.76B | 144.02% |
| Dec 29, 2023 | 8.92B | 66.28% |
| Dec 30, 2022 | 5.36B | -10.83% |
| Dec 31, 2021 | 6.01B | -32.22% |
| Aug 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 62.67B |
| Innova Captab | 62.04B |
| Orchid Pharma | 49.71B |
| RPG Life Sciences | 43.91B |
| Ind-Swift Laboratories | 29.00B |
| Solara Active Pharma Sciences | 26.50B |
| Beta Drugs | 24.22B |
| Indoco Remedies | 20.55B |